» Articles » PMID: 38638067

Etiological Changes of Liver Cirrhosis and Hepatocellular Carcinoma-complicated Liver Cirrhosis in Japan: Updated Nationwide Survey from 2018 to 2021

Overview
Journal Hepatol Res
Specialty Gastroenterology
Date 2024 Apr 19
PMID 38638067
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: A nationwide survey in 2018 showed decreasing involvement of viral hepatitis and increasing involvement of nonviral liver diseases in the etiology of liver cirrhosis (LC) in Japan. An updated nationwide survey was undertaken in 2023.

Methods: Cases of LC diagnosed between 2018 and 2021 were collected from 75 institutions, and the etiologies of LC were investigated. In addition, the data obtained were compared with the results of previous studies.

Results: Among the 15 517 cases, alcohol-related liver disease (ALD)-associated LC was the most frequent cause (n = 5,487, 35.4%). Hepatitis C virus-associated LC, nonalcoholic steatohepatitis (NASH)-associated LC, and hepatitis B virus-associated LC were ranked as second, third, and fourth, respectively. In comparison to the previous survey, the ratios of viral hepatitis-associated LC decreased (HBV: from 11.5% to 8.1%; HCV: from 48.2% to 23.4%), while the ratios of ALD-associated LC and NASH-associated LC increased (from 19.9% to 35.4% and from 6.3% to 14.6%, respectively). Regarding cases of LC with hepatocellular carcinoma (n = 5906), HCV-associated LC (1986 cases, 33.6%) was the most frequent cause. Alcohol-related liver disease-associated LC, NASH-associated LC, and HBV-associated LC were the second-, third-, and fourth-ranked causes, respectively. In comparison to the previous survey, as the cause of hepatocellular carcinoma-complicated LC, HCV-associated LC decreased from 60.3% to 33.6%, while the ratios of ALD-associated LC and NASH-associated LC increased from 14.2% to 28.6% and from 4.2% to 14.0%, respectively.

Conclusions: The major causes of LC in Japan are suggested to have been shifting from viral hepatitis to nonviral chronic liver diseases.

Citing Articles

Efficacy of measuring natural killer-activating receptor ligands to predict the pathogenesis of metabolic dysfunction-associated steatotic liver disease.

Arai J, Okumura A, Kimoto S, Sakamoto K, Kitada T, Kitano R Hepatol Int. 2025; .

PMID: 40085416 DOI: 10.1007/s12072-025-10800-y.


Impact of Alcohol Intake on Skeletal Muscle: A Large Cross-Sectional Analysis in Japanese Adults.

Matsui M, Fukuda A, Onishi S, Ushiro K, Nishikawa T, Asai A Nutrients. 2025; 17(5).

PMID: 40077764 PMC: 11901683. DOI: 10.3390/nu17050894.


Possible Use of Body Surface Area Value for Estimating Skeletal Muscle Mass in Chronic Liver Disease.

Yoh K, Nishimura T, Ikeda N, Takashima T, Aizawa N, Yuri Y Diagnostics (Basel). 2025; 15(3).

PMID: 39941193 PMC: 11817660. DOI: 10.3390/diagnostics15030263.


Clinical Applications of Artificial Intelligence (AI) in Human Cancer: Is It Time to Update the Diagnostic and Predictive Models in Managing Hepatocellular Carcinoma (HCC)?.

Romeo M, Dallio M, Napolitano C, Basile C, Di Nardo F, Vaia P Diagnostics (Basel). 2025; 15(3).

PMID: 39941182 PMC: 11817573. DOI: 10.3390/diagnostics15030252.


Long-term Effect of the HCV Elimination With Direct-acting Antivirals on the Progression of Gastroesophageal Varices.

Yuri Y, Nishimura T, Ikeda N, Takashima T, Aizawa N, Kimura T In Vivo. 2024; 38(6):2968-2972.

PMID: 39477391 PMC: 11535916. DOI: 10.21873/invivo.13779.